Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test

RegulatoryapprovedAdvanceAD-TxPositive

AI Analysis

Summary

Castle Biosciences announced approval of its AdvanceAD-Tx test by the New York State Department of Health. The approval represents a regulatory milestone for the diagnostic test.

Outcome Details

New York State Department of Health approval

Importance:6/10

Sentiment:

0.70

regulatory approvaldiagnosticsstate approvalAdvanceAD-Tx

Related Companies

$CSTL

Read the original article

Published by yahoo_finance on July 14, 2026 8:30 PM

Read Original